10-Q/A: Quarterly report (Amendment)
Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic Developments
Zura Bio Is Maintained at Outperform by Oppenheimer
Zura Bio Is Maintained at Outperform by Oppenheimer
Express News | Zura Bio Limited : Oppenheimer Raises Target Price to $21 From $16
Express News | Zura Bio Ltd : Guggenheim Cuts Target Price to $15 From $20
10-Q: Quarterly report
Zura Bio 1Q Loss/Shr 2c >ZURA
Zura Bio 1Q Loss/Shr 2c >ZURA
Zura Bio 1Q Loss $7.75M >ZURA
Zura Bio 1Q Loss $7.75M >ZURA
Express News | Zura Bio Ltd: Projected Cash Runway Extends Support for Operations Through 2027
Express News | Zura Bio Ltd: On Track to Initiate Phase 2 Studies Evaluating Tibulizumab (Zb-106) for Treatment of Systemic Sclerosis (Ssc) in Q4 2024
Express News | Zura Bio Q1 Operating Expenses USD 8.379 Million
Express News | Zura Bio Q1 EPS USD -0.02 Vs. Ibes Estimate USD -0.23
Express News | Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
Zura Bio Initiated at Overweight by Piper Sandler
Zura Bio Initiated at Overweight by Piper Sandler
Express News | Piper Sandler Initiates Coverage On Zura Bio With Overweight Rating, Announces Price Target of $26
Analysts Are Bullish on These Healthcare Stocks: Irhythm Technologies (IRTC), Zura Bio (ZURA)
Express News | Venrock Healthcare Capital Partners III,L.p. Reports Passive Stake of 9.99% in Zura Bio Ltd as of April 22, 2024
Behind The Uptrend: Understanding Zura Bio (ZURA) Stock Surge
The shares of Zura Bio Limited (NASDAQ: ZURA) are currently witnessing a remarkable surge, demonstrating a significant increase of 20.17% during the current trading session, reaching a value of $4.35. This substantial uptrend in the price of ZUR stock follows recent equity actions, as there is no immediate discernible catalyst directly responsible for this surge. ...
12 Health Care Stocks Moving In Friday's Intraday Session
GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 61.4% to $1.17 during Friday's regular session. The company's market cap stands at $5.1 million. Agenus (NASDAQ:AGEN) shares rose 32.53% to $11.
Zura Bio Insider Bought Shares Worth $3,715,000, According to a Recent SEC Filing
Someit Sidhu, Director, on April 22, 2024, executed a purchase for 1,186,901 shares in Zura Bio (ZURA) for $3,715,000. Following the Form 4 filing with the SEC, Sidhu has control over a total of 3,675
No Data